Leading the Fight Against Cancer
We equip students with the interdisciplinary education, laboratory experience and career skills they’ll need to excel in cancer research.
M.S. Info Sessions
The past two decades have seen a revolution in the study of cancer biology. Advances in molecular biology, biochemistry and cell biology have contributed to our understanding of malignant transformation, cancer prevention and cancer therapy. The Georgetown University Interdisciplinary Program in Tumor Biology provides doctoral and master’s students with an excellent academic environment and interdisciplinary training for a career in cancer biology research. Our students develop their potential to produce highest-quality research and academic scholarship.
Join Us in 2026!
M.S. Fall 2026 Priority Application: May 15
M.S. Fall 2026 Final Deadline: July 1
Attend an online information session to learn about our programs:
The Georgetown Difference
Our program brings together about 60 faculty members from basic science and clinical departments, as well as the expertise and resources of Georgetown’s Lombardi Comprehensive Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center that combines excellence in basic and clinical cancer research, as well as research on cancer control and prevention.
A combination of formal courses, seminars, and ongoing collaborative research projects bring together faculty and trainees in a unified doctoral program committed to providing quality education in cancer biology, prevention, and therapy.
Alumni Success
Coursework, lab experience, mentorship and career development resources all empower our students to pursue impactful careers.
M.S. Alumni Outcomes M.S. and Ph.D. Career ServicesNews
Cancer Frontiers Symposium Highlights Treatment Challenges, Emerging Technologies
Biomedical Graduate Education (BGE) faculty and students in December hosted a symposium focused on challenges and possibilities in cancer treatment. “Cancer Frontiers: Rare Cancer, Emerging Technolo…
January 28th, 2026
Research Finds New Tool to Predict Long-Term Heart Risk After Breast Cancer Treatment
Breast cancer survivors are known to be at higher risk for cardiovascular conditions. Georgetown and MedStar researchers developed a statistical model to identify factors that put a patient at higher …
January 26th, 2026
Inaugural Thomas A. Reynolds III Return to Function Challenge Grant Recipients Selected
Faculty from a variety of BGE programs are involved with two translational science teams, working to improve stroke recovery and fight Parkinson’s disease. The teams’ new funding aims to advance one o…
January 14th, 2026